PROGNOSIS IMPACT OF KRAS AND BRAF MUTATIONS ON LOCALLY ADVANCED AND/OR METASTATIC PANCREATIC CANCER PATIENTS: A PROSPECTIVE MULTICENTER STUDY

(1) Gastroenterology

(2) INSERM U858, CHU Rangueil, Toulouse

(3) INSERM U755, University Saint Pères, Paris

(4) Digestive Surgery, CHU Rangueil, Toulouse

(5) Oncology, Val d'Aurelle Center, Montpellier

(6) CIC, CHU Nord, Marseille

(7) Gastroenterology, CHU Beaujon, Clichy, France

(8) Oncology, CHU Rangueil, Toulouse, France



This item was part of the PANCREAS III session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A535